TARO - Taro Pharmaceutical Industries Ltd.

NYSE - NYSE Delayed Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending3/31/20193/31/20183/31/20173/31/2016
Current Assets
Cash And Cash Equivalents567,451576,611600,399576,757
Short Term Investments481,883846,009786,361651,869
Net Receivables276,614320,016324,418284,049
Inventory148,079144,595141,045138,553
Other Current Assets1,0621,455136,489216,411
Total Current Assets1,482,7201,896,6351,999,0241,877,595
Long Term Investments304,322225,63970,685115,173
Property, plant and equipment190,747183,957180,085159,459
Goodwill7,1917,2017,1927,198
Intangible Assets24,34716,8625,9288,334
Accumulated Amortization----
Other Assets125,999102,91626,83920,274
Deferred Long Term Asset Charges110,97487,25710,3244,007
Total Assets2,135,3262,433,2102,289,7532,188,033
Current Liabilities
Accounts Payable35,06025,69716,39418,853
Short/Current Long Term Debt----
Other Current Liabilities109,333111,916117,664135,276
Total Current Liabilities216,821215,756209,837245,462
Long Term Debt----
Other Liabilities7,3837,0556,1105,427
Deferred Long Term Liability Charges----
Minority Interest5,5865,2416,3126,002
Negative Goodwill----
Total Liabilities224,204222,811215,947250,889
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock680680680680
Retained Earnings2,481,0292,662,3272,451,1771,994,821
Treasury Stock-838,618-720,294-646,808-326,804
Capital Surplus262,445262,445262,445262,445
Other Stockholder Equity-144,108-110,285-148,133-123,026
Total stockholders' equity1,905,5362,205,1582,067,4941,931,142
Net Tangible Assets1,873,9982,181,0952,054,3741,915,610